Platelet — Vessel Wall Interactions in Individuals who Smoke Cigarettes
Sudden cardiac death is the most frequent cause of mortality in industrialized societies accounting for the majority of the over 325,000 smoking-related deaths each year in the United States1. The strong link between cigarette smoking and the platelet-modulated syndrome of sudden cardiac death2,3 implicates smoking as a cause of platelet activation. Consistent with this hypothesis of a direct activation of platelets is that platelet turnover appears to be accelerated in apparently healthy smokers4,5. However, an enhanced turnover of platelets may be the result of their increased clearance following membrane alterations after interaction with a damaged vasculature and conversely, thrombosis has been shown to occur in vivo without evidence of increased turnover6–8. Thus, an enhanced platelet turnover in smokers may not necessarily reflect a direct activation of platelets in vivo. In fact, ex vivo aggregation has been found to be either increased9,10, unchanged4,12–14 or significantly decreased15,16 in chronic smokers.
KeywordsCigarette Smoking Platelet Activation Urinary Metabolite Aspirin Treatment Chronic Smoker
Unable to display preview. Download preview PDF.
- 8.H. M. Graves, R. L. Kinlough-Rathbone, M. Richardson, L. Jorgensen, S. Moore and J. F. Mustard. Thrombin generation and fibrosis formation following injury to rabbit neointima: Studies of vessel wall reactivity and platelet survival. Lab. Invest. 46:605 (1982).Google Scholar
- 11.K. G. Schmidt and J. W. Rasmussen. Acute platelet activation-induced by smoking: in vivo and ex vivo studies in man. Throm. Haemost. 51:279 (1984).Google Scholar
- 17.B. Samuelsson. The role of prostaglandin endoperoxides and thromboxanes as bioregulators. in: “Proceedings of the Intrascience Symposium on the New Biochemistry of Prostaglandins and Thromboxanes.” N. Kharsch and J. Fried, eds., Publisher New York Academic Press, Santa Monica, CA (1977).Google Scholar
- 23.P. Ribeiro, R. Walesby, S. Edmonson, A. V. Jadhar, I. Traynor, C. M. Oakley and G. R. Thompson. Collagen content of atherosclerotic arteries is higher in smokers than in nonsmokers. Lancet 2:107 (1983).Google Scholar
- 26.J. L. Nadler, J. S. Velasco and R. Horton. Cigarette smoking inhibits prostacyclin formation. Lancet 1:248 (1983).Google Scholar
- 29.J. J. Murray, J. Nowak, J. A. Oates and G. A. FitzGerald. Biosynthesis of thromboxane A2 and prostacyclin during chronic smoking and withdrawal in man. Clin. Res. 33:521A (1985).Google Scholar
- 32.J.J. Murray, J. Nowak, J. A. Oates and G. A. FitzGerald. Platelet function during chronic smoking and withdrawal. Clin. Res. 33:350A (1985).Google Scholar
- 36.Å. Wennmalm. Smoking induced alterations in thromboxane biosynthesis: a population study. Presented at the Winter Prostaglandin Conference. Keystone, CO (1988).Google Scholar
- 40.G. A. FitzGerald, A. R. Brash, I. A. Blair and J. Lawson. Analysis of urinary metabolites of thromboxane and prostacyclin by negative ion-chemical ionization gas chromatography-mass spectrometry. Adv. Prostglandin Thromboxane Res. 15:87 (1985).Google Scholar
- 45.J. J. Belch, B. M. McArdle, P. Burns, G. D. Lowe and C. D. Forbes. The effects of acute smoking on platelet behaviour, fibrinolysis haemarheology in habitual smokers. Thromb. Haemostasis 51:6 (1984).Google Scholar
- 47.R. Doll and A. B. Hill. Mortality in relation to smoking: Ten years’ observation of British doctors. Br. Med. J. 1:1406 (1964).Google Scholar